The Biotechnology Industry
Organization (BIO) will be holding its annual BIO International Convention April
22-25, 2013 in Chicago, IL. Founded in
1993, BIO is a nonprofit association seeking supportive biotechnology policies
on behalf of more than 1,100 biotechnology companies, academic institutions,
state biotechnology centers, and related organizations across the United States
and in more than 30 other nations. The
BIO International Convention serves to educate the public and policymakers
about biotechnology, while fostering partnering meetings and other business
development activities to keep the biotech industry growing.
An electronic version of the Convention program, including descriptions of the Convention's 125+ Breakout Sessions and six Super Sessions, can be accessed here. Among the sessions that may be of interest to Patent Docs readers are:
April 22, 2013
• How IP Issues Impact
Innovations in Biomarker Diagnostics & Personalized Medicine -- 10:15 AM -
11:30 AM
• Behind the Tech Transfer
Headlines: What are You Missing? - 10:15 AM - 11:30 AM
• Trends in Biotech IP Law
in Canada and the U.S. -- 2:30 PM - 3:30 PM
• The Unitary Patent: How
Will it Affect the Biotech Sector and Your Business? -- 3:45 PM - 5:00 PM --
panel moderated by Patent Docs author
Donald Zuhn
April 23, 2013
• Multi-Party and
Cross-Border Patent Issues Affecting Biotech Businesses -- 9:00 AM - 10:15 AM
• Ernst & Young’s
Beyond Borders Report 2013 (Super Session) -- 10:00 AM - 11:30 AM
• Myriad, Mayo, and Beyond:
Developments in the Law of Patentable Subject Matter - 10:30 AM - 11:30 AM
• Burrill
State-of-the-Industry Report (Super Session) -- 2:00 PM - 3:30 PM
• The Compulsory Licensing
Trend: Increased Access, or Lost Opportunities and Unintended Consequences? -- 2:30
PM - 3:30 PM
• Biosimilars: Strategic
Considerations for Regulatory Approval and Patents under the BPCIA --3:45 PM -
5:00 PM
April 24, 2013
• IP Strategies for the
Developing World -- 9:00 AM - 10:15 AM
• The Morning After!: What
to Do in U.S. & European Patent Prosecution Following the Enactment of AIA
-- 10:30 AM - 11:30 AM
• Finding Innovation in
Emerging Markets -- 10:30 AM - 11:30 AM
• Emerging Markets: A
Discussion with the Heads of Patent Offices -- 3:45 PM - 5:00 PM
• Scientific American
WORLDVIEW (Super Session) -- 3:45 PM - 5:15 PM
As part of the Convention, more than 2,000 biotech companies, organizations, and institutions will participate in the BIO Exhibition. A searchable list of exhibitors can be found here. Information regarding registration and pricing can be obtained here. Patent Docs Donald Zuhn, Kevin Noonan, Sherri Oslick, James DeGiulio, Andrew Williams, and Kwame Mensah will be attending BIO as part of the MBHB contingent, and will be reporting on a number of the sessions listed above. Patent Docs readers who may be attending BIO are encouraged to stop by the MBHB booth (#3684).
Comments